| |
| |
|
| Insider
Information: |
Mancini Marianna |
| Relationship: |
Chief Operating Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
348,508 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$27,950,342 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
348,508 |
|
|
| Total
Value |
$27,950,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viking Therapeutics, Inc. |
VKTX |
Chief Operating Officer |
2024-05-01 |
348,508 |
2021-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-05-01 |
4 |
AS |
$76.40 |
$22,136,474 |
D/D |
(281,425) |
348,508 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-05-01 |
4 |
OE |
$4.68 |
$1,740,575 |
D/D |
281,425 |
629,933 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-27 |
4 |
D |
$83.34 |
$1,384,277 |
D/D |
(16,610) |
363,565 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
31,667 |
380,175 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-01 |
4 |
D |
$85.22 |
$1,445,161 |
D/D |
(16,958) |
348,508 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
31,667 |
365,466 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-01-04 |
4 |
D |
$18.58 |
$263,817 |
D/D |
(14,199) |
333,799 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
98,334 |
380,675 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-01-03 |
4 |
D |
$17.40 |
$856,254 |
D/D |
(49,210) |
347,998 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-04-17 |
4 |
AS |
$20.00 |
$250,000 |
D/D |
(12,500) |
287,763 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-04-17 |
4 |
OE |
$13.07 |
$163,375 |
D/D |
12,500 |
300,263 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-03-29 |
4 |
AS |
$16.00 |
$659,872 |
D/D |
(41,242) |
261,895 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-03-29 |
4 |
OE |
$9.13 |
$136,950 |
D/D |
15,000 |
303,137 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-03-28 |
4 |
AS |
$15.00 |
$2,948,445 |
D/D |
(196,563) |
288,137 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-03-28 |
4 |
OE |
$1.04 |
$397,193 |
D/D |
167,427 |
484,700 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-15 |
4 |
D |
$8.95 |
$9,657 |
D/D |
(1,079) |
317,273 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-04 |
4 |
D |
$8.42 |
$117,829 |
D/D |
(13,994) |
318,352 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
D |
$8.52 |
$160,636 |
D/D |
(18,854) |
332,346 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
90,667 |
351,200 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-30 |
4 |
D |
$9.40 |
$120,066 |
D/D |
(12,773) |
260,533 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,500 |
273,306 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-15 |
4 |
D |
$4.24 |
$3,506 |
D/D |
(827) |
238,695 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-04 |
4 |
D |
$4.62 |
$54,724 |
D/D |
(11,845) |
239,522 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-03 |
4 |
D |
$4.88 |
$19,125 |
D/D |
(3,919) |
174,034 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
77,333 |
251,367 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
